Copyright
©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 807-815
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.807
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.807
Table 2 Associations between sarcopenia status and outcomes
Outcome | n | Sarcopenia Median (IQR) or n (%)] | No Sarcopenia Median (IQR) or n (%)] | P value |
Post-op survival for 90 d | 55 | 23 (88) | 26 (90) | 1.000 |
Post-op survival for 1 yr | 52 | 19 (76) | 22 (81) | 0.740 |
Post-op survival for 5 yr | 41 | 13 (59) | 13 (68) | 0.746 |
ICU length of stay (d) | 55 | 3 (2, 4) | 2 (2, 5) | 0.696 |
Readmission to ICU | 54 | 4 (15) | 4 (14) | 1.000 |
Total length of stay (d) | 55 | 13.5 (10, 27) | 21 (9, 28) | 0.661 |
Intubation days | 55 | 1.5 (1, 3) | 1 (1, 3) | 0.484 |
Pulmonary complications | 54 | 10 (38) | 5 (18) | 0.131 |
Need for dialysis | 54 | 6 (23) | 7 (25) | 1.000 |
Readmission within 30 d | 55 | 13 (50) | 13 (45) | 0.790 |
PNF | 55 | 2 (8) | 0 (0) | 0.219 |
Acute rejection | 55 | 2 (8) | 4 (14) | 0.672 |
Arterial complications | 55 | 6 (23) | 5 (17) | 0.739 |
Biliary complications | 55 | 8 (31) | 10 (34) | 1.000 |
- Citation: Dhaliwal A, Larson D, Hiat M, Muinov LM, Harrison WL, Sayles H, Sempokuya T, Olivera MA, Rochling FA, McCashland TM. Impact of sarcopenia on mortality in patients undergoing liver re-transplantation. World J Hepatol 2020; 12(10): 807-815
- URL: https://www.wjgnet.com/1948-5182/full/v12/i10/807.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i10.807